Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CRMD – CorMedix Inc.

CorMedix Inc.
CRMD
$11.09
Name : CorMedix Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $865,671,040.00
EPSttm : 0.78
finviz dynamic chart for CRMD
CorMedix Inc.
$11.09
4.07%
$0.47

Float Short %

23.93

Margin Of Safety %

19

Put/Call OI Ratio

0.43

EPS Next Q Diff

0.45

EPS Last/This Y

2.08

EPS This/Next Y

0.65

Price

11.08

Target Price

20.5

Analyst Recom

1.29

Performance Q

-2.29

Relative Volume

0.64

Beta

1.81

Ticker: CRMD




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-09-08CRMD12.750.300.2553854
2025-09-09CRMD13.010.310.2054789
2025-09-10CRMD12.780.320.0355222
2025-09-11CRMD13.090.310.1555977
2025-09-12CRMD12.940.310.9756736
2025-09-15CRMD12.640.350.6560390
2025-09-16CRMD11.550.360.7461145
2025-09-17CRMD11.120.352374978369960.4760638297872362523
2025-09-18CRMD11.690.340.0763159
2025-09-22CRMD11.280.430.2639106
2025-09-23CRMD11.450.430.2942357
2025-09-24CRMD11.240.421.2544630
2025-09-25CRMD11.110.451.3846138
2025-09-26CRMD11.330.470.0947827
2025-09-29CRMD11.850.460.0748968
2025-09-30CRMD11.630.420.2952667
2025-10-01CRMD11.050.420.9952996
2025-10-02CRMD11.040.440.1855051
2025-10-03CRMD11.330.440.0855616
2025-10-06CRMD11.550.430.4956071
2025-10-07CRMD11.090.430.7757344
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-09-08CRMD12.75876.7- 1.67
2025-09-09CRMD13.02888.0- 1.67
2025-09-10CRMD12.79888.0- 1.67
2025-09-11CRMD13.09888.0- 1.67
2025-09-12CRMD12.94888.0- 1.67
2025-09-15CRMD12.65888.0- 1.67
2025-09-16CRMD11.59888.0- 1.67
2025-09-17CRMD11.13888.0- 1.67
2025-09-18CRMD11.67888.0- 1.67
2025-09-19CRMD11.19888.0- 1.72
2025-09-22CRMD11.27908.0- 1.72
2025-09-23CRMD11.44908.0- 1.72
2025-09-24CRMD11.24908.0- 1.72
2025-09-25CRMD11.12908.0- 1.75
2025-09-26CRMD11.30908.0- 1.78
2025-09-29CRMD11.85962.9- 1.78
2025-09-30CRMD11.62962.9- 1.78
2025-10-01CRMD11.06962.9- 1.78
2025-10-02CRMD11.04962.9- 1.78
2025-10-03CRMD11.32962.9- 1.78
2025-10-06CRMD11.56962.9- 1.78
2025-10-07CRMD11.08962.9- 1.78
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-09-08CRMD0.0046.6821.28
2025-09-09CRMD0.0046.6821.28
2025-09-10CRMD0.0046.6821.28
2025-09-11CRMD0.0046.6817.84
2025-09-12CRMD-1.2846.6817.83
2025-09-15CRMD-1.8946.9817.83
2025-09-16CRMD-1.8946.9817.83
2025-09-17CRMD-2.0146.9817.83
2025-09-18CRMD-2.0146.9817.83
2025-09-19CRMD-1.9246.9817.05
2025-09-22CRMD-1.9350.1317.06
2025-09-23CRMD-1.9250.1317.06
2025-09-24CRMD-1.9250.1317.06
2025-09-25CRMD-1.9250.1323.93
2025-09-26CRMD-1.9250.1323.93
2025-09-29CRMD-1.9249.8023.93
2025-09-30CRMD-1.9249.8023.93
2025-10-01CRMD-1.9249.8023.93
2025-10-02CRMD-1.9249.8023.93
2025-10-03CRMD-1.9249.8023.93
2025-10-06CRMD-1.9218.4223.93
2025-10-07CRMD-1.9218.4223.93
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.28

Avg. EPS Est. Current Quarter

0.43

Avg. EPS Est. Next Quarter

0.73

Insider Transactions

-1.92

Institutional Transactions

18.42

Beta

1.81

Average Sales Estimate Current Quarter

65

Average Sales Estimate Next Quarter

102

Fair Value

13.14

Quality Score

100

Growth Score

64

Sentiment Score

78

Actual DrawDown %

41.1

Max Drawdown 5-Year %

-84.5

Target Price

20.5

P/E

14.85

Forward P/E

4.56

PEG

P/S

7.13

P/B

3.75

P/Free Cash Flow

28.47

EPS

0.75

Average EPS Est. Cur. Y​

1.78

EPS Next Y. (Est.)

2.43

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

42.11

Relative Volume

0.64

Return on Equity vs Sector %

-2

Return on Equity vs Industry %

11.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.43

EBIT Estimation

CorMedix Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 64
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
stock quote shares CRMD – CorMedix Inc. Stock Price stock today
news today CRMD – CorMedix Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CRMD – CorMedix Inc. yahoo finance google finance
stock history CRMD – CorMedix Inc. invest stock market
stock prices CRMD premarket after hours
ticker CRMD fair value insiders trading